Research and experimental development on natural sciences and engineering
PERIOVACX AS
Operating profit
NOK −13,000
Equity
NOK −200,000
Incorporated
2016
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 13k | |
| Operating profit (EBIT) | −13k | |
| Net financial items | 4 | |
| Profit for the year | −13k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 1k | |
| of which current assets | 1k | |
| Equity | −200k | |
| Total liabilities | 202k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.